Back

A novel receptor-interacting protein-1 (RIP1) inhibitor (547) protects human cardiac cells from ischemia/reperfusion-triggered necroptotic cell death

29 April 2022 (00:00 - 00:00)
Organised by: Logo
Congress Presentation Part of: Poster Session 1 Ischaemia, Infarction, Cardioprotection CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2022 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Marijn Peters

University Medical Center Utrecht, Utrecht (Netherlands (The))

73 More presentations in this session

Presentation thumbnail
Inflammatory mediators to predict left adverse ventricular remodelling in revascularized STEMI patients
Miss E. Bevilacqua (Seville, ES)
Abstract
Presentation thumbnail
Silent myocardial infarction in non-insulin dependent type 2 diabetes mellitus patients with low adherence to blood glucose monitoring
Doctor K. Viligorska (Chernivtsi, UA)
Abstract
Presentation thumbnail
Implication of caveolae in the pathophysiology of human acute myocardial infarction: a histological study
Mr C. Rios Navarro (Valencia, ES)
Abstract
Presentation thumbnail
Ang 1-7 mitigates the thapsigargin induced lowered myocardium tolerance to ischemia and reperfusion
Associate Professor L. Tacu (Chisinau, MD)
Presentation thumbnail
Searching for cardioprotective microRNA families by bioinformatics analysis of cross-species transcriptomic datasets
Doctor B. Agg (Budapest, HU)
Abstract

Access the full session

Session thumbnail
Poster Session 1

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2022

29 April - 1 May 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources